EMEA-001039-PIP02-12-M04

Key facts

Invented name
  • Xeomin
  • Bocouture
Active substance
Clostridium Botulinum neurotoxin type A (150 kD), free from complexing proteins
Therapeutic area
  • Neurology
  • Ophthalmology
Decision number
P/0125/2020
PIP number
EMEA-001039-PIP02-12-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of sialorrhoea
Route(s) of administration
  • Intraglandular use
  • Intramuscular use
Contact for public enquiries
Merz Pharmaceuticals GmbH

Tel. +49 6915031
E-mail: contact@merz.de

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating